搜索
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
DMIIR添加自选
0.081USD
+0.000+0.25%
收盘 07/02, 13:00（美东）报价延迟15分钟
0.00总市值
--市盈率 TTM
关于 Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 公司
Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030简介
公司代码DMIIR
公司名称Drugs Made In America Acquisition II Corp
上市日期Sep 25, 2025
CEOStockwell (Lynn)
员工数量- -
证券类型Right
年结日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33301
电话19548703099
网址
公司代码DMIIR
上市日期Sep 25, 2025
CEOStockwell (Lynn)
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
常见问题
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030的前五大股东是谁？
Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 的前五大股东如下：Ms. Lynn Stockwell